Dabalos, Luzviena T.

HRN: 28-69-94  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/17/2026
03/24/2026
IV
500mg
BID
TYPHOID FEVER, INTRA ABDOMINAL INFECTION
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: